pancreatic cancer

You have access
FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines
SEBASTIAN K.S. BEGG, DAVID J. BIRNBAUM, JEFFREY W. CLARK, MARI MINO-KENUDSON, ULRICH F. WELLNER, OLIVER SCHILLING, KEITH D. LILLEMOE, ANDREW L. WARSHAW, CARLOS FERNÁNDEZ-DEL CASTILLO and ANDREW S. LISS

Anticancer Research July 2020, 40 (7) 3659-3667; DOI: https://doi.org/10.21873/anticanres.14355
You have access
Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer
AUSRA LUKOSIUTE-URBONIENE, AUGUSTINA MAZEIKE, MINTAUTE KAZOKAITE, GIEDRE SILKUNIENE, MANTAS SILKUNAS, VIDMANTAS BARAUSKAS, GIEDRIUS BARAUSKAS, ANTANAS GULBINAS, ALBERTAS DAUKSA and ZILVINAS DAMBRAUSKAS

Anticancer Research July 2020, 40 (7) 3765-3779; DOI: https://doi.org/10.21873/anticanres.14366
You have access
Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature
SHOHEI T. BURNS, LLOYD DAMON, NAOMI AKAGI, ZOLTAN LASZIK and ANDREW H. KO

Anticancer Research July 2020, 40 (7) 3995-4000; DOI: https://doi.org/10.21873/anticanres.14393
You have access
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
JEAN-DAVID FUMET, JULIE VINCENT, LEILA BENGRINE, AUDREY HENNEQUIN, LAURA GRANCONATO, REMI PALMIER and FRANÇOIS GHIRINGHELLI

Anticancer Research July 2020, 40 (7) 4011-4015; DOI: https://doi.org/10.21873/anticanres.14395
You have access
Effectiveness of Photodynamic Screening Using 5-Aminolevulinic Acid for the Diagnosis of Pancreatic Cancer
TSUKASA IKEURA, YUICHI HORI, TOSHIYUKI MITSUYAMA, HIDEAKI MIYOSHI, MASAAKI SHIMATANI, KAZUSHIGE UCHIDA, MAKOTO TAKAOKA, URARA OTA, ATSUKO KAMIYA, KIWAMU TAKAHASHI, MASAHIRO ISHIZUKA, MASAKI KAIBORI and KAZUICHI OKAZAKI

Anticancer Research June 2020, 40 (6) 3571-3577; DOI: https://doi.org/10.21873/anticanres.14347
You have access
New Pancreatic Cancer Biomarkers eIF1, eIF2D, eIF3C and eIF6 Play a Major Role in Translational Control in Ductal Adenocarcinoma
NICOLE GOLOB-SCHWARZL, PHILIP PUCHAS, MARGIT GOGG-KAMERER, WILKO WEICHERT, BENJAMIN GÖPPERT and JOHANNES HAYBAECK

Anticancer Research June 2020, 40 (6) 3109-3118; DOI: https://doi.org/10.21873/anticanres.14292
You have access
Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Locally Recurrent Pancreatic Cancer After Surgical Resection
CHRISTOPHER MÅNSSON, ANDERS NILSSON, PETER NYGREN and BRITT-MARIE KARLSON

Anticancer Research May 2020, 40 (5) 2771-2775; DOI: https://doi.org/10.21873/anticanres.14249
You have access
Pathogenesis and Treatment of Pancreatic Cancer Related Pain
INES LOHSE and SHAUN P. BROTHERS

Anticancer Research April 2020, 40 (4) 1789-1796; DOI: https://doi.org/10.21873/anticanres.14133
You have access
Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
FUMINORI SONOHARA, SUGURU YAMADA, SHIGEOMI TAKEDA, MASAMICHI HAYASHI, MASAYA SUENAGA, YUKI SUNAGAWA, MITSURU TASHIRO, HIDEKI TAKAMI, MITSURO KANDA, CHIE TANAKA, DAISUKE KOBAYASHI, GORO NAKAYAMA, MASAHIKO KOIKE, MICHITAKA FUJIWARA and YASUHIRO KODERA

Anticancer Research April 2020, 40 (4) 1843-1853; DOI: https://doi.org/10.21873/anticanres.14138
You have access
Characterization of Pancreatic and Biliary Cancer Stem Cells in Patient-derived Tissue
JULIA GOGOLOK, ELISABETH SEIDEL, ANNIKA STRÖNISCH, ANJA REUTZEL-SELKE, IGOR M. SAUER, JOHANN PRATSCHKE, MARCUS BAHRA and ROSA B. SCHMUCK

Anticancer Research March 2020, 40 (3) 1267-1275; DOI: https://doi.org/10.21873/anticanres.14068

Main menu

User menu

Search

pancreatic cancer

Pages